Astellas Pharma Inc.: U.S. FDA Approves Expanded Label for Astellas' IZERVAY (avacincaptad pegol intravitreal solution) for Geographic Atrophy
IZERVAY dosing approved beyond 12 months TOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today ...
New research links Ozempic to vision loss and risk of blindness
Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...
Popular Weight Loss Drugs Ozempic And Mounjaro Make You Go Blind? Doctors Weigh In
A new study suggests a possible link between GLP-1 weight loss drugs like Ozempic and Mounjaro and vision problems, including sudden vision loss. Researchers are investigating whether these ...